Quantum Leap Award

Launching ideas to commercialization

In 2023, the Indiana Biosciences Research Institute (IBRI) unveiled the Quantum Leap Award in partnership with inaugural sponsor, Roche Diagnostics. The IBRI was proud to partner with Roche on this innovative effort that supported the creation of opportunities and outcomes that would otherwise not occur.

Translation of innovation in a startup company can be challenging. We understand that startups need many levels of support to take ideas from concept to commercialization. That’s why we created a competition that is about more than access to lab space; it's about enabling the best science to leap forward through access to capabilities and collaboration.

The winner of the Quantum Leap Award received up to two wet lab biology benches rent free for one calendar year, use of desks in co-working space with conference room access, and participation in our AXIS Mentoring Program, as well as a cash prize of $50,000 to support research.

The Quantum Leap Awardee gained access to shared equipment as seen in our lab video. Additionally, the awardee had the opportunity to:

  • Contract with the IBRI to partner with our scientific capabilities:
    • Small molecule or antibody drug discovery platforms.
    • Enabling technologies (e.g., bioinformatics and computational biology; and advanced cellular pharmacology).
    • IPSC technology.
  • Use the IBRI's state-of-the-art drug discovery laboratory.
  • Access group pricing for license of drug discovery platforms (e.g., Schrodinger Suite of Tools, CDD Vault), and lab supplies.
IBRI logo

About the IBRI

At the IBRI, our scientists work daily on powerful discoveries to defeat challenging biomedical problems without solutions, like diabetes, Alzheimer’s disease and pediatric rare diseases while providing molecular innovation and antibody drug discovery platforms and enabling technologies to translate the research of today into tomorrow’s patient needs.

Roche logo

About Roche

Founded in 1896 in Basel, Switzerland, as one of the first industrial manufacturers of branded medicines, Roche has grown into the world’s largest biotechnology company and the global leader in in-vitro diagnostics. The company pursues scientific excellence to discover and develop medicines and diagnostics for improving and saving the lives of people around the world. We are a pioneer in personalized healthcare and want to further transform how healthcare is delivered to have an even greater impact. To provide the best care for each person we partner with many stakeholders and combine our strengths in Diagnostics and Pharma with data insights from the clinical practice.

In recognizing our endeavor to pursue a long-term perspective in all we do, Roche has been named one of the most sustainable companies in the pharmaceuticals industry by the Dow Jones Sustainability Indices for the thirteenth consecutive year. This distinction also reflects our efforts to improve access to healthcare together with local partners in every country we work.

Genentech, in the United States, is a wholly-owned member of the Roche Group. Roche is the majority shareholder in Chugai Pharmaceutical, Japan.

For more information, please visit www.roche.com.

IBRI scientist working in lab

Welcome to Our Open Space Laboratories

The IBRI is a leading translational research institute that advances academic and industry science through collaboration to improve patient health outcomes.